Company Profiles

driven by the PitchBook Platform

GenomOncology

GenomOncology
2012 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
5 INVESTORS
Description

Provider of a genetic information analysis platform designed to addresses the full range of needs in precision medicine. The company's genetic information analysis platform is used to speed up the process of analyzing sequenced genetic information, enabling healthcare institutions to improve cancer care through precision medicine.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Biotechnology
Primary Office
1375 East 9th Street
Suite 1120
Cleveland, OH 44114
United States

+1 (440) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GenomOncology’s full profile, request a free trial.

GenomOncology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 05-Feb-2014 00.00 Completed Startup
3. Early Stage VC (Series A) 13-Sep-2013 000 00.00 0000 Completed Startup
2. Early Stage VC 05-Jun-2012 $250K $1.5M Completed Startup
1. Seed Round 01-Apr-2012 $1.25M $1.25M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

GenomOncology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Sparc PE/Buyout Minority 000 0000 000000 0
TriStar Health Partners Venture Capital Minority 000 0000 000000 0
JumpStart Venture Capital Minority 000 0000 000000 0
North Coast Angel Fund Angel Group Minority 000 0000 000000 0
Zapis Capital Group Venture Capital Minority 000 0000 000000 0

GenomOncology Executive Team (11)

Name Title Board
Seat
Contact
Info
Manuel Glynias President, Chief Executive Officer & Board Member
Victor Peroni Chief Financial Officer
David Lasecki Chief Strategy Officer
Teresa Fletcher Vice President, Business Development
Ian Maurer Vice President, Product Development

5 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

GenomOncology Board Members (5)

Name Representing Role Since Contact
Info
Bradley Wertz Self Chairman 000 0000
Brian Laden Ph.D TriStar Health Partners Board Member 000 0000
John Doulis MD Self Board Member 000 0000
Lee Zapis Zapis Capital Group Board Member 000 0000
Manuel Glynias GenomOncology President, Chief Executive Officer & Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com